Antimicrobial Therapeutic Drug Monitoring Workshop

Strong associations exist between drug exposure and patient outcomes for many antimicrobials. Therapeutic drug monitoring (TDM) is an obvious method to apply to ensure more patients achieve effective drug concentrations and should be considered standard-of-care for most antimicrobials. However, there is still uncertainty and inconsistency of practice about which patients would most benefit from TDM, which antimicrobial concentration targets should be used and what methods are feasible and could be applied to effectively change doses. In this workshop, we address these issues as they relate to antibacterials, antifungals and antimycobacterials. We also present new technological advances that improve the feasibility and accuracy of antimicrobial TDM, and specific considerations for key settings including paediatrics and outpatients (and critically ill patients of course!) as well as the place of dosing software. Watch our recordings to hear from leading practitioners and scientists in this area!

Antimicrobial Therapeutic Drug Monitoring Workshop

Wednesday, 11 November 2020, Virtual Event, delivered by zoom

Workshop Programme
Time Topic Speaker
Session 1: Dose Optimisation and PK PD                                                                                                                                                            Chair Prof Jason Roberts
0900-0905 Welcome Prof Jason Roberts (Brisbane)

The need for antimicrobial dose optimisation

Prof Jason Roberts (Brisbane)

Different approaches to antimicrobial dose optimisation

Mr Paul Williams (Sunshine Coast)

Antibacterial pharmacokinetic-pharmacodynamic targets

Dr Kathryn Daveson (Canberra)

Antifungal pharmacokinetic-pharmacodynamic targets

Dr Hafiz Abdul-Aziz (Brisbane)

Antimycobacterial pharmacokinetic-pharmacodynamic targets

Dr Andrew Burke (Brisbane)
1045-1105 Morning Tea (20min)
Session 2: Therapeutic Drug Monitoring Concepts Chair Dr Suzanne Parker (Brisbane)

Principles of therapeutic drug monitoring (TDM)

A/Prof Darren Roberts (Sydney)

Outcome and cost-effectiveness data supporting antimicrobial TDM

Dr Gloria Wong (Brisbane)

Considerations for TDM in paediatrics

Dr Amanda Gwee (Melbourne)

Antimicrobial susceptibility testing considerations for TDM

Prof John Turnidge (Adelaide)

Study design considerations to quantify the clinical value of TDM

Prof Jan-Willem Alffenaar (Sydney)
1245-1345 Lunch (60min)
Session 3: Dosing Software Chair Dr Andrew Burke (Brisbane)

Use of TDM in the outpatient setting

Dr Kate McCarthy (Brisbane)

Technological advances to revolutionise TDM: Sampling and Bioanalytics

Dr Suzanne Parker (Brisbane)

Technological advances to revolutionise TDM: Dosing software

Mr Gene Chai (Brisbane)

IDS-ODS Dosing Software

Dr Andras Farkas (New York)
1515-1545 Afternoon tea (30min)
Session 4: Dosing Software Practical Applications Chair Prof Jason Roberts (Brisbane)

IDS-ODS case studies: vancomycin and meropenem

Mr Paul Williams and Mr Gene Chai (Brisbane)
1630-1640 Close Prof Jason Roberts
1640-1800 Dinner break (80min)  
Session 5: European Perspectives Chair Dr Claire Roger (Nîmes)
AEST CET Topic Speaker
1800-1805 0900-0905

Welcome from Nîmes

Dr Claire Roger  (Nîmes)
1805-1825 0905-0925

International Guidelines for antimicrobial TDM

Dr Jan De Waele (Belgium)
1830-1850 0930-0950

Dosing software for optimising therapy

Dr Sylvain Goutelle
1855-1915 0955-1015

Dosing challenges in obese patients

Prof Bernard Allaouchiche
1920-1940 1020-1040

Vancomycin use in Europe

Prof Marc Leone
1945-2005 1045-1105

TDM of linezolid and daptomycin

Dr Sonia Luque
2010-2030 1110-1130 Close Dr Claire Roger

View more videos on the CRE REDUCE YouTube channel

Thank you to our sponsors.



Therapeutic Drug Monitoring Workshop

Wed 11 Nov 2020 8:45am8:30pm


Zoom details will be provided upon registration.

This event is co-organised by CRE REDUCE, UQ and CHU Nîmes.




Luminita Vlad
07 3346 5045